4//SEC Filing
Ballinger Kevin J. 4
Accession 0001225208-20-004422
CIK 0000885725other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:10 PM ET
Size
9.9 KB
Accession
0001225208-20-004422
Insider Transaction Report
Form 4
Ballinger Kevin J.
SVP & Pres, Interven Cardio
Transactions
- Exercise/Conversion
Common Stock
2020-03-03+3,303→ 83,388 total - Tax Payment
Common Stock
2020-03-03$37.23/sh−1,507$56,106→ 81,881 total - Sale
Common Stock
2020-03-04$38.05/sh−1,796$68,338→ 80,085 total - Exercise/Conversion
Deferred Stock Units
2020-03-03−3,303→ 6,606 totalExp: 2022-03-03→ Common Stock (3,303 underlying)
Footnotes (4)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- [F3]This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- [F4]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001566080
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:10 PM ET
- Size
- 9.9 KB